PD-L1 Protein Expression Is Associated With Good Clinical Outcomes and Nomogram for Prediction of Disease Free Survival and Overall Survival in Breast Cancer Patients Received Neoadjuvant Chemotherapy

OBJECTIVE: This study aims to investigate the potential prognostic significance of programmed death ligand-1 (PD-L1) protein expression in tumor cells of breast cancer patients received neoadjuvant chemotherapy (NACT). METHODS: Using semiquantitative immunohistochemistry, the PD-L1 protein expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li, Huang, Shaolong, Liu, Qiang, Kong, Xiangyi, Su, Zhaohui, Zhu, Mengliu, Fang, Yi, Zhang, Lin, Li, Xingrui, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163312/
https://www.ncbi.nlm.nih.gov/pubmed/35669769
http://dx.doi.org/10.3389/fimmu.2022.849468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163312/
https://www.ncbi.nlm.nih.gov/pubmed/35669769
http://dx.doi.org/10.3389/fimmu.2022.849468

Ejemplares similares